Henry J Fuchs insider trades: Biomarin Pharmaceutical (BMRN) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Henry reports to the SEC
and 1 more company
Open-market buys and sales
102 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Mar 5, 2024 | BMRN | ↓ Sell | 35,341 | $85.18 | $3.0M | Direct | Mar 7, 2024 (2d) |
| Aug 10, 2023 | BMRN | ↓ Sell | 12,000 | $90.43 | $1.1M | Direct | Aug 11, 2023 (1d) |
| Feb 11, 2022 | MRTX | ↓ Sell | 11,000 | $105.61 | $1.2M | Direct | Feb 14, 2022 (3d) |
| Dec 15, 2020 | MRTX | ↓ Sell | 10,000 | $233.39 | $2.3M | Direct | Dec 16, 2020 (1d) |
| Aug 10, 2020 | MRTX | ↓ Sell | 10,000 | $131.38 | $1.3M | Direct | Aug 11, 2020 (1d) |
| Jul 20, 2020 | BMRN | ↓ Sell | 126,389 | $130.00 | $16.4M | Direct | Jul 22, 2020 (2d) |
| Jul 13, 2020 | BMRN | ↓ Sell | 23,011 | $130.00 | $3.0M | Direct | Jul 15, 2020 (2d) |
| Apr 24, 2020 | BMRN | ↓ Sell | 20,000 | $95.88 | $1.9M | Direct | Apr 28, 2020 (4d) |
| Apr 20, 2020 | BMRN | ↓ Sell | 17,213 | $90.00 | $1.5M | Direct | Apr 22, 2020 (2d) |
| Mar 25, 2019 | BMRN | ↓ Sell | 5,932 | $87.86 | $521K | Direct | Mar 26, 2019 (1d) |
| Mar 18, 2019 | BMRN | ↓ Sell | 9,597 | $94.09 | $903K | Direct | Mar 19, 2019 (1d) |
| Mar 4, 2019 | BMRN | ↓ Sell | 2,196 | $95.00 | $209K | Direct | Mar 6, 2019 (2d) |
| Feb 25, 2019 | GHDX | ↓ Sell | 30,000 | $81.55 | $2.4M | Direct | Feb 26, 2019 (1d) |
| Aug 27, 2018 | BMRN | ↓ Sell | 25,000 | $99.50 | $2.5M | Direct | Aug 28, 2018 (1d) |
| Jun 14, 2018 | BMRN | ↓ Sell | 31,000 | $90.00 | $2.8M | Direct | Jun 18, 2018 (4d) |
| Apr 2, 2018 | BMRN | ↓ Sell | 10,000 | $80.12 | $801K | Direct | Apr 3, 2018 (1d) |
| Jan 2, 2018 | BMRN | ↓ Sell | 15,000 | $89.23 | $1.3M | Direct | Jan 4, 2018 (2d) |
| Sep 15, 2017 | BMRN | ↓ Sell | 15,000 | $90.50 | $1.4M | Direct | Sep 19, 2017 (4d) |
| Jun 19, 2017 | BMRN | ↓ Sell | 15,000 | $90.00 | $1.4M | Direct | Jun 20, 2017 (1d) |
| Feb 24, 2017 | BMRN | ↓ Sell | 15,000 | $87.99 | $1.3M | Direct | Feb 28, 2017 (4d) |
| Nov 25, 2016 | BMRN | ↓ Sell | 15,000 | $87.40 | $1.3M | Direct | Nov 29, 2016 (4d) |
| Aug 26, 2016 | BMRN | ↓ Sell | 15,000 | $95.06 | $1.4M | Direct | Aug 30, 2016 (4d) |
| May 26, 2016 | BMRN | ↓ Sell | 15,000 | $87.81 | $1.3M | Direct | May 31, 2016 (5d) |
| Jun 5, 2015 | BMRN | ↓ Sell | 1,864 | $122.32 | $228K | Direct | Jun 8, 2015 (3d) |
| May 18, 2015 | BMRN | ↓ Sell | 1,864 | $124.78 | $233K | Direct | May 19, 2015 (1d) |
| May 13, 2015 | BMRN | ↓ Sell | 1,434 | $121.37 | $174K | Direct | May 14, 2015 (1d) |
| May 11, 2015 | BMRN | ↓ Sell | 2,869 | $121.64 | $349K | Direct | May 12, 2015 (1d) |
| May 1, 2015 | BMRN | ↓ Sell | 414 | $114.59 | $47K | Direct | May 5, 2015 (4d) |
| Mar 16, 2015 | BMRN | ↓ Sell | 41,315 | $123.57 | $5.1M | Direct | Mar 18, 2015 (2d) |
| Nov 10, 2014 | BMRN | ↓ Sell | 20,000 | $86.55 | $1.7M | Direct | Nov 12, 2014 (2d) |
| Aug 5, 2014 | BMRN | ↓ Sell | 10,000 | $65.00 | $650K | Direct | Aug 7, 2014 (2d) |
| May 16, 2014 | BMRN | ↓ Sell | 1,864 | $56.86 | $106K | Direct | May 19, 2014 (3d) |
| May 13, 2014 | BMRN | ↓ Sell | 1,434 | $58.23 | $83K | Direct | May 14, 2014 (1d) |
| May 9, 2014 | BMRN | ↓ Sell | 3,479 | $57.91 | $201K | Direct | May 12, 2014 (3d) |
| May 1, 2014 | BMRN | ↓ Sell | 715 | $59.67 | $43K | Direct | May 5, 2014 (4d) |
| Feb 3, 2014 | BMRN | ↓ Sell | 10,000 | $67.70 | $677K | Direct | Feb 4, 2014 (1d) |
| Jan 2, 2014 | BMRN | ↓ Sell | 916 | $68.97 | $63K | Direct | Jan 6, 2014 (4d) |
| Sep 19, 2013 | BMRN | ↓ Sell | 10,000 | $80.19 | $802K | Direct | Sep 23, 2013 (4d) |
| Sep 5, 2013 | BMRN | ↓ Sell | 10,000 | $70.00 | $700K | Direct | Sep 9, 2013 (4d) |
| Jul 1, 2013 | BMRN | ↓ Sell | 10,000 | $60.00 | $600K | Direct | Jul 2, 2013 (1d) |
| Jun 3, 2013 | BMRN | ↓ Sell | 1,098 | $58.32 | $64K | Direct | Jun 5, 2013 (2d) |
| May 23, 2013 | BMRN | ↓ Sell | 20,609 | $66.29 | $1.4M | Direct | May 24, 2013 (1d) |
| Apr 30, 2013 | BMRN | ↓ Sell | 20,000 | $63.29 | $1.3M | Direct | May 1, 2013 (1d) |
| Nov 5, 2012 | BMRN | ↓ Sell | 10,000 | $46.00 | $460K | Direct | Nov 7, 2012 (2d) |
| Nov 1, 2012 | BMRN | ↓ Sell | 5,000 | $37.08 | $185K | Direct | Nov 5, 2012 (4d) |
| Oct 1, 2012 | BMRN | ↓ Sell | 5,000 | $39.75 | $199K | Direct | Oct 3, 2012 (2d) |
| Sep 4, 2012 | BMRN | ↓ Sell | 5,000 | $37.76 | $189K | Direct | Sep 6, 2012 (2d) |
| Aug 1, 2012 | BMRN | ↓ Sell | 5,000 | $38.63 | $193K | Direct | Aug 2, 2012 (1d) |
| Jul 2, 2012 | BMRN | ↓ Sell | 15,000 | $40.19 | $603K | Direct | Jul 5, 2012 (3d) |
| Jun 1, 2012 | BMRN | ↓ Sell | 5,000 | $35.02 | $175K | Direct | Jun 4, 2012 (3d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other BMRN insiders
Open-market trades in the last 12 months
About Henry J Fuchs's insider trades
Henry J Fuchs is President, Worldwide R&D at Biomarin Pharmaceutical (BMRN). Since Nov 16, 2006, Henry has reported no open-market purchases and 102 sales worth $77.1M on SEC Form 4. There have been no open-market trades in the last 12 months.
11 sales (2% of the value sold) were made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so they say little about how the insider sees the stock today.
Their filings also include grants and awards (93 filings), option exercises (73 filings), shares withheld for taxes (35 filings), shares returned to the company (6 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every BMRN insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.